DENTSPLY SIRONA (XRAY) officer logs RSU dividend and phantom stock grants

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. VP and Chief Accounting Officer Kevin Czerney reported routine equity-related awards. On January 9, 2026, he acquired 262.7169 shares of common stock at $0, representing dividends paid in the form of additional restricted stock units that follow the same vesting schedule as the underlying RSUs, each converting into one share of common stock.

On the same date, he also acquired 4.0523 shares of phantom stock under the Dentsply Supplemental Savings Plan and 45.13 shares of phantom stock under the Supplemental Executive Retirement Plan at an economic value of $12.22 per phantom share, each economically equivalent to one share of common stock and payable in stock upon termination of employment. Following these transactions, his reported holdings increased to 28,040.786 shares of common stock, 341.201 phantom shares in the savings plan, and 3,493.4336 phantom shares in the retirement plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Czerney Kevin

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		262.7169(1)	A	$0	28,040.786(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Dentsply Supplemental Savings Plan) DSSP	(4)	01/09/2026		A		4.0523(5)		(4)	(4)	Common Stock	4.0523	$12.22	341.201	D
Phantom Stock (Supplemental Executive Retirement Plan) SERP	(4)	01/09/2026		A		45.13		(4)	(4)	Common Stock	45.13	$12.22	3,493.4336	D

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

2. Includes 514 shares acquired between July 1st - December 31, 2025 under the Dentsply Sirona Employee Stock Purchase Plan.

3. Includes 112.122 shares acquired through dividend reinvestment on 1/9/2026.

4. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

5. Comprised of phantom stock acquired as a result of accrued dividends.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Kevin Czerney	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did DENTSPLY SIRONA (XRAY) report for Kevin Czerney?

VP and Chief Accounting Officer Kevin Czerney reported the acquisition of 262.7169 shares of DENTSPLY SIRONA common stock through RSU dividends and additional phantom stock units in company benefit plans on January 9, 2026.

How many DENTSPLY SIRONA common shares does Kevin Czerney hold after this Form 4?

After the reported transaction, Kevin Czerney beneficially owns 28,040.786 shares of DENTSPLY SIRONA common stock, including amounts accumulated through the employee stock purchase plan and dividend reinvestment.

What is the nature of the 262.7169 DENTSPLY SIRONA shares acquired at $0?

The 262.7169 common shares represent dividends on restricted stock units (RSUs) credited as additional RSUs, which vest on the same schedule as the underlying awards and convert into common stock on a 1:1 basis.

What are the phantom stock awards reported for XRAY’s VP and Chief Accounting Officer?

Kevin Czerney acquired 4.0523 phantom stock units under the Dentsply Supplemental Savings Plan and 45.13 phantom stock units under the Supplemental Executive Retirement Plan, each economically equivalent to one share of common stock.

When do the phantom stock units reported by XRAY become payable?

Each share of phantom stock is economically equivalent to one share of common stock and becomes payable in common stock upon the reporting person’s termination of employment.

How many phantom stock units does Kevin Czerney hold after these transactions?

Following the transactions, Kevin Czerney holds 341.201 phantom stock units in the Dentsply Supplemental Savings Plan and 3,493.4336 phantom stock units in the Supplemental Executive Retirement Plan.

Did the Form 4 indicate any sales of DENTSPLY SIRONA stock by Kevin Czerney?

No sales are listed; all reported transactions have transaction code "A", indicating acquisitions of common stock via RSU dividends and phantom stock units in benefit plans.